Cognition Therapeutics Inc

CGTX NASDAQ Healthcare & Biotech United States US19243B1026
1.01 $
3.33 %

Cognition Therapeutics is focused on the discovery and development of drugs for the treatment of neurodegenerative disorders, such as Alzheimer's disease.